This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| ICD-10 | M45.5 |
| Synonyms / related terms | Ankylosing spondylitis with thoracolumbar junction involvement, Anderson lesion, thoracolumbar AS |
| Special Copayment Reduction | V140 — Severe intractable disease (copayment 10%, 5 years) |
| Main age of onset | Onset at ages 15-35; thoracolumbar junction involvement progresses during long-standing disease |
Contents
| s1 | History |
| s2 | Causes |
| s3 | Genetics |
| s4 | General epidemiology |
| s5 | Pathophysiology |
| s6 | Symptoms |
| s7 | Signs |
| s8 | Screening |
| s9 | Diagnosis |
| s10 | Treatment |
| s11 | Prognosis |
| s12 | Prevention |
| s13 | References |
Involvement of the thoracolumbar junction (TLJ, T10-L2 region) in ankylosing spondylitis (AS) is the biomechanical turning point where the rigidity of the thoracic spine meets the mobility of the lumbar spine and has important significance in the clinical course of AS. This is a site where spinal biomechanical stress is concentrated, and it is one of the sites where AS fractures occur most frequently. Historically, AS spinal fracture studies in the 1970s-80s reported a high frequency of thoracolumbar junction fractures, and neurological injury (paraplegia or incomplete injury) after fractures at this site came to be recognized as a major complication in AS patients. Radiographically, syndesmophytes of the thoracolumbar junction, Anderson lesion (aseptic spondylodiscitis, pseudarthrosis), and segmental bony fusion are characteristic of AS at this site. Early detection of active inflammation by MRI and subsequent biologic treatment are showing effectiveness in suppressing pathologic progression at this site. Surgery at this site (nerve decompression, fracture fixation) is technically demanding because of its biomechanical complexity, and multidisciplinary collaboration among rheumatology, neurosurgery, and rehabilitation medicine is essential.
Thoracolumbar junction AS shares the risk factors of systemic AS (HLA-B27, long disease duration, smoking, male sex), and the unique biomechanics of this site act as an additional risk factor. Between the fixed thoracic spine (fixed by the ribs) and the mobile lumbar spine, mechanical stress is concentrated at this site during flexion and extension. When the thoracic spine is partially fused by syndesmophytes with AS progression, greater stress is applied to the thoracolumbar junction, and the fracture risk rises sharply, especially when osteoporotic bone quality coexists. The Anderson lesion (pseudarthrosis or noninfectious spondylitis) is relatively common at this site, with repetitive mechanical stress and local osteoporosis contributing. Smoking accelerates radiographic progression of the thoracolumbar junction and reduces response to biologic treatment.
The genetic basis of thoracolumbar junction AS follows the genetic factors of systemic AS. HLA-B27, ERAP1, and IL23R are central, and studies of independent genetic factors for the occurrence of Anderson lesions are limited. Because Anderson lesions in AS occur at sites of repeated trauma, local osteoporosis, and incomplete bony fusion, osteoporosis-related genetic factors (VDR, LRP5, COL1A1) may contribute. Polymorphisms of the DKK-1 and sclerostin genes affect the imbalance between bone formation and bone resorption in AS and may determine the degree of reactive bone formation at the thoracolumbar junction. Polygenic risk score analysis for the risk of thoracolumbar junction involvement has not yet been performed.
Separate epidemiologic studies of thoracolumbar junction AS are rare, but there are reports from AS spinal fracture studies that fractures at this site account for about 30-40% of all AS spinal fractures. Anderson lesions (noninfectious spondylodiscitis) of the thoracolumbar junction are identified by radiographs or MRI in about 1-8% of AS patients and occur most frequently at this site. Osteoporosis is widespread in AS patients, and L1-L2 bone density tends to be underestimated because it is not as easy to follow radiographically as the fused thoracic spine. Anderson lesions are more frequent in patients with a long AS disease duration and high disease activity. Male sex, smoking, discontinuation of NSAIDs, and non-use of biologics are risk factors for radiographic progression at this site.
The pathology of thoracolumbar junction AS begins with enthesis inflammation at the disc-vertebral junctions of this site. Repetitive mechanical load is concentrated on the anterior cartilaginous endplates and ligament attachment sites of the T10-L2 region, promoting chronic enthesis inflammation and reactive bone formation. The Anderson lesion is understood as destruction of disc tissue at this site and formation of pseudarthrosis through noninfectious cytokine-mediated inflammation. When repeated external force is applied to a segment with incomplete bony fusion, a stress fracture or traumatic fracture occurs. In a complete fracture, injury at the junction of the spinal cord (T10-L1) and the cauda equina (L2 and below) can cause combined lower limb motor and sensory paralysis and bladder and bowel dysfunction. If spinal canal stenosis progresses in the long term, neurogenic claudication and cauda equina symptoms may appear.
Symptoms of thoracolumbar AS are characterized by thoracic back-lumbar transition pain (worse at rest, relieved by exercise), lower thoracic radiating pain (radiating to the front of the abdomen along the T10-L2 segmental nerve distribution), and morning stiffness. When an Anderson lesion is present, local tenderness at the site is severe, and a mechanical pain component that worsens with movement is added. Lower limb nerve root symptoms (low back pain, radiating pain, paresthesia) radiate to the groin, anterior thigh, and medial side with L1-L2 nerve root compression. Neurogenic claudication due to spinal canal stenosis (lower limb numbness and weakness on walking, improving after rest) may appear. In a thoracolumbar junction fracture, sudden worsening of local pain, lower limb motor and sensory abnormalities, and bladder and bowel dysfunction present as emergency symptoms. Because the neural supply of intra-abdominal organs overlaps with the T10-L2 segments, differentiation from abdominal pain is needed.
On physical examination, spinous process tenderness and percussion pain at the thoracolumbar junction (T10-L2) and flank pain trigger points are checked. Lumbar range of motion is quantified with the Schober test and the modified Schober test. Along with chest wall expansion, lateral thoracoabdominal expansion is also checked. Lower limb neurological examination: lower lumbar nerve root function is also evaluated, including L1 (medial cutaneous branch of the femoral nerve sensation), L2 (lateral femoral cutaneous nerve distribution), the patellar tendon reflex (L3-L4), and the Achilles tendon reflex (S1). When an Anderson lesion is present, local pain at the site worsens sharply on anterior spinal loading (flexion of the thoracolumbar junction). Evaluation of osteoporosis risk factors (age, steroid use, reduced mobility) is also performed.
For screening of thoracolumbar junction AS, anteroposterior and lateral thoracic and lumbar radiographs are performed regularly to assess Anderson lesions, syndesmophytes, and vertebral compression fractures. MRI (thoracic and lumbar, T2/STIR) evaluates active bone marrow edema, differentiation of inflammation vs. mechanical pseudarthrosis in Anderson lesions, and spinal cord or epidural abnormalities. CT is essential for evaluating the presence of fracture and bony structure. Bone density measurement (DEXA, L1-L4 and femur) is included in osteoporosis assessment, taking into account that bony fusion at this site can make DEXA values higher than the actual values. The ASDAS, BASDAI, and neurological function assessment are performed regularly. When bladder dysfunction is suspected, urodynamic studies are performed.
A diagnosis of thoracolumbar junction AS is established when, in a patient meeting AS criteria, characteristic AS findings at this site (syndesmophytes, Anderson lesion, bony fusion, active bone marrow edema) are identified on radiographs or MRI. For Anderson lesions, differentiation from pyogenic spondylodiscitis and tuberculous spondylitis is essential, and for this purpose MRI signal characteristics, fever/inflammatory markers, blood culture, PPD, and serum antibody tests are performed. CT-guided fine-needle aspiration biopsy is used when exclusion of infection is inadequate. When neurological symptoms appear, emergency MRI and neurosurgical consultation are needed.
Drug treatment of thoracolumbar junction AS follows the standard systemic AS protocol. TNF inhibitors are effective when the Anderson lesion includes an active inflammatory component, and surgical stabilization is needed when the mechanical pseudarthrosis component predominates. In the presence of progressive neurological symptoms (neurogenic claudication, precursors of paraplegia), nerve decompression (laminectomy, foraminotomy) and, if necessary, fusion are performed. For thoracolumbar junction fractures, surgical fixation (percutaneous screw fixation, posterior fusion) is decided according to instability and neurological status. Concomitant osteoporosis treatment and fall prevention are essential for managing fracture risk. Respiratory rehabilitation and spinal stabilization exercises are added.
The prognosis of AS with thoracolumbar junction involvement is determined by the presence of an Anderson lesion, the occurrence of fracture, and whether neurological complications coexist. The prognosis is good when the Anderson lesion is stabilized with TNF inhibitors. After a thoracolumbar junction fracture, paraplegia or incomplete paraplegia can partly recover with early surgical management, but recovery is difficult in complete injury. Progressive neurogenic claudication can have functional improvement with appropriate decompression surgery. TNF/IL-17 inhibitor administration slows the rate of radiographic progression at this site, but reversal of already formed bony fusion is not possible. Early detection of conversion of the Anderson lesion to active inflammation and of precursor findings of fracture through regular MRI and clinical monitoring is key to improving prognosis.
Prevention of thoracolumbar junction AS consists of early diagnosis, thorough anti-inflammatory treatment, smoking cessation, exercise rehabilitation, and osteoporosis management. For patients with an Anderson lesion, TNF inhibitors are administered early to suppress the active inflammatory component of noninfectious spondylodiscitis. Fall risk management (environmental modification, balance training, non-slip measures) and education on avoiding violent spinal loading are needed. Correction of working posture is important so that repetitive impact is not applied to the thoracolumbar junction during long-distance driving or activities with heavy vibration. Osteoporosis treatment is essential as primary prevention of fractures at this site. Regular thoracic and lumbar radiographic and MRI follow-up allows early detection of the occurrence of Anderson lesions and precursors of fracture.
1. van der Linden S, et al. Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheum. 1984;27(4):361-8.
2. Sieper J, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002;61(Suppl 3):iii8-18.
3. Braun J, et al. ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70(6):896-904.
4. Poddubnyy D, et al. Rates and predictors of radiographic spinal progression in AS. Ann Rheum Dis. 2011;70(8):1369-74.
5. Baraliakos X, et al. MRI in AS: patterns of spinal changes. Rheumatology. 2017;56(3):421-32.
6. Reveille JD. Genetics of spondyloarthritis — beyond the MHC. Nat Rev Rheumatol. 2012;8(5):296-304.
7. Klingberg E, et al. Osteoporosis in ankylosing spondylitis — prevalence, risk factors and methods of assessment. Arthritis Res Ther. 2012;14(3):R108.
8. Ramiro S, et al. ASAS-EULAR recommendations for AS management: 2022 update. Ann Rheum Dis. 2023;82(1):19-34.
9. Kim TH, et al. Spondyloarthropathies in Korea: prevalence and clinical characteristics. J Korean Med Sci. 2021;36(12):e96.
10. Wanders AJ, et al. NSAIDs inhibit radiographic progression in AS. Arthritis Rheum. 2005;52(6):1756-65.